Abacus FCF Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-16,182
Closed -$1.84M 166
2020
Q4
$1.84M Sell
16,182
-1,515
-9% -$167K 1.07% 49
2020
Q3
$1.92M Buy
17,697
+10,993
+164% +$1.1M 1.03% 49
2020
Q2
$624K Sell
6,704
-4,992
-43% -$479K 0.59% 81
2020
Q1
$1.05M Sell
11,696
-1,188
-9% -$126K 1.2% 40
2019
Q4
$1.46M Sell
12,884
-297
-2% -$32.6K 1.15% 17
2019
Q3
$1.43M Buy
13,181
+31
+0.2% +$3.23K 1.18% 16
2019
Q2
$1.28M Sell
13,150
-1,485
-10% -$136K 1.05% 43
2019
Q1
$1.33M Buy
14,635
+693
+5% +$62K 1.03% 49
2018
Q4
$1.27M Buy
+13,942
New +$1.3M 1.16% 16

Other funds holding MDT

Abacus FCF Advisors's MDT Position: Q1 2021 in Review

Abacus FCF Advisors sold out of Medtronic (MDT) in Q1 2021, closing a stake of 16,182 shares — an estimated $1.84M sold.

Abacus FCF Advisors first reported a position in MDT in Q4 2018 and held it in 9 quarters. The position peaked at $1.92M in Q3 2020. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

  • Abacus FCF Advisors reported no remaining Medtronic position as of Q1 2021 after selling out during the quarter.
  • Abacus FCF Advisors sold 16,182 Medtronic shares in Q1 2021, an estimated $1.84M.
  • Abacus FCF Advisors first reported a position in Medtronic in Q4 2018 and held it in 9 quarters.
  • Abacus FCF Advisors's Medtronic position peaked at $1.92M in Q3 2020.
  • 1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on Abacus FCF Advisors's 13F filing for Q1 2021, filed 6 Apr 2021.